BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
9/7/2022 8:29:04 AM | Browse: 657 | Download: 1613
 |
Received |
|
2022-01-27 12:45 |
|
Peer-Review Started |
|
2022-01-27 12:46 |
|
First Decision by Editorial Office Director |
|
2022-02-24 06:56 |
|
Return for Revision |
|
2022-02-24 06:56 |
|
Revised |
|
2022-03-05 15:38 |
 |
Publication Fee Transferred |
|
|
|
Second Decision by Editor |
|
2022-07-21 03:10 |
|
Second Decision by Editor-in-Chief |
|
|
|
Final Decision by Editorial Office Director |
|
2022-07-26 17:37 |
|
Articles in Press |
|
2022-07-26 17:37 |
|
Edit the Manuscript by Language Editor |
|
2022-08-22 16:56 |
|
Typeset the Manuscript |
|
2022-08-26 00:40 |
|
Publish the Manuscript Online |
|
2022-09-07 08:29 |
| ISSN |
1007-9327 (print) and 2219-2840 (online) |
| Open Access |
This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/Licenses/by-nc/4.0/ |
| Copyright |
© The Author(s) 2022. Published by Baishideng Publishing Group Inc. All rights reserved. |
| Article Reprints |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
|
| Permissions |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
|
| Publisher |
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA |
| Website |
http://www.wjgnet.com |
| Category |
Transplantation |
| Manuscript Type |
Review |
| Article Title |
Therapeutic strategies for post-transplant recurrence of hepatocellular carcinoma
|
| Manuscript Source |
Invited Manuscript |
| All Author List |
Carlo Sposito, Davide Citterio, Matteo Virdis, Carlo Battiston, Michele Droz Dit Busset, Maria Flores and Vincenzo Mazzaferro |
| ORCID |
|
| Funding Agency and Grant Number |
|
| Corresponding Author |
Carlo Sposito, MD, Assistant Professor, Surgeon, HPB Surgery, Hepatology and Liver Transplantation, Fondazione IRCCS Istituto Nazionale Tumori di Milano, Via Venezian 1, Milan 20133, Italy. carlo.sposito@istitutotumori.mi.it |
| Key Words |
Liver transplantation; Hepatocellular carcinoma; Immunosuppression; Recurrence; Surgical treatment; Locoregional treatment; Systemic treatment |
| Core Tip |
Hepatocellular carcinoma (HCC) is becoming the most common indication to liver transplantation (LT). The problem of tumor recurrence after LT, that occurs in up to 20% of cases, is becoming of increasing interest. In this paper, we performed a review of the available literature on the topic of HCC recurrence after LT. The best preventive measures still rely on pre-transplant selection criteria, since no dedicated follow up guidelines exist and no post-LT adjuvant treatments are available. When recurrence occurs, the prognosis is poor: However, an aggressive surgical treatment, particularly in case of late recurrence, may provide a significant survival benefit. |
| Publish Date |
2022-09-07 08:29 |
| Citation |
Sposito C, Citterio D, Virdis M, Battiston C, Droz Dit Busset M, Flores M, Mazzaferro V. Therapeutic strategies for post-transplant recurrence of hepatocellular carcinoma. World J Gastroenterol 2022; 28(34): 4929-4942 |
| URL |
https://www.wjgnet.com/1007-9327/full/v28/i34/4929.htm |
| DOI |
https://dx.doi.org/10.3748/wjg.v28.i34.4929 |
All content on this site: Copyright © 1993-2026 Baishideng Publishing Group Inc, its licensors, and contributors. All rights are reserved, including those for text and data mining, AI training, and similar technologies. For all open access content, the relevant licensing terms apply.
